At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AMLX Amylyx Pharmaceuticals
Closed 10-21 16:00:00 EDT
29.03
+0.26
+0.90%
盘后28.60
-0.43-1.48%
19:30 EDT
High29.78Low28.81Vol1.63M
Open28.96D1 Closing28.77Amplitude3.35%
Mkt Cap3.66BTradable Cap3.19BTotal Shares126.00M
T/O47.56MT/O Rate1.48%Tradable Shares110.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Ukraine strikes Russian refinery as Zelensky defies Trump over truceZelensky says Ukraine’s patience has run out after Russia continued bombing its energy infrastructure.3 min read
7NEWS  ·  10-16
Ukraine strikes Russian refinery as Zelensky defies Trump over truceZelensky says Ukraine’s patience has run out after Russia continued bombing its energy infrastructure.3 min read
Amylyx price target raised to $39 from $32 at Citi
TIPRANKS  ·  10-15
Amylyx price target raised to $39 from $32 at Citi
NUE Power Adds Tony Clement to Board as Nuclear and SMR Push Accelerates
TIPRANKS  ·  10-15
NUE Power Adds Tony Clement to Board as Nuclear and SMR Push Accelerates
Amylyx Director George M. Milne Jr Disposes of 30,000 Common Shares Worth $830,904
Reuters  ·  10-08
Amylyx Director George M. Milne Jr Disposes of 30,000 Common Shares Worth $830,904
NUE Power Sharpened Focus on Canadian Energy Projects After Leadership Overhaul
TIPRANKS  ·  10-08
NUE Power Sharpened Focus on Canadian Energy Projects After Leadership Overhaul
What Amylyx Pharmaceuticals (AMLX)'s Phase 3 Data Presentation Means For Shareholders
Simply Wall St.  ·  10-07
What Amylyx Pharmaceuticals (AMLX)'s Phase 3 Data Presentation Means For Shareholders
Amylyx to Present Phase 3 Lucidity Topline Data for Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek 2026
Reuters  ·  10-06
Amylyx to Present Phase 3 Lucidity Topline Data for Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek 2026
3 High Growth Stocks To Own In October 2026
Simply Wall St.  ·  10-06
3 High Growth Stocks To Own In October 2026
APA seals CS Energy deal for $1.3bn Brigalow peaking plant
TIPRANKS  ·  09-30
APA seals CS Energy deal for $1.3bn Brigalow peaking plant
White House proposes investing $5B in Middle East energy rebuild, WSJ says
TIPRANKS  ·  09-22
White House proposes investing $5B in Middle East energy rebuild, WSJ says
AI Construction Group Buildots Raises $130M to Keep Data Center Rollout on Schedule
TIPRANKS  ·  09-15
AI Construction Group Buildots Raises $130M to Keep Data Center Rollout on Schedule
Canaan Converts Crypto Treasury Into Buybacks as August 2026 Mining Output Holds Steady
TIPRANKS  ·  09-14
Canaan Converts Crypto Treasury Into Buybacks as August 2026 Mining Output Holds Steady
Onterris awarded contract worth over C$9M by Canadian energy infrastructure co.
TIPRANKS  ·  09-14
Onterris awarded contract worth over C$9M by Canadian energy infrastructure co.
Brent Crude Surges Past $102 as Escalating U.S.-Iran Conflict Drives Energy Inflation Concerns
TIPRANKS  ·  09-10
Brent Crude Surges Past $102 as Escalating U.S.-Iran Conflict Drives Energy Inflation Concerns
Amylyx inks long-term manufacturing deal for avexitide
TIPRANKS  ·  09-09
Amylyx inks long-term manufacturing deal for avexitide
Amylyx Pharmaceuticals - Bachem and Polypeptide to be Non-Exclusive Suppliers for Amylyx - SEC Filing
THOMSON REUTERS  ·  09-09
Amylyx Pharmaceuticals - Bachem and Polypeptide to be Non-Exclusive Suppliers for Amylyx - SEC Filing
Amylyx Pharmaceuticals - Polypeptide Agreement Includes Fixed Volume-Based Pricing with Annual Adjustment - SEC Filing
THOMSON REUTERS  ·  09-09
Amylyx Pharmaceuticals - Polypeptide Agreement Includes Fixed Volume-Based Pricing with Annual Adjustment - SEC Filing
Amylyx Pharmaceuticals - Bachem Manufacturing Agreement Has Initial 5 Year Term, Auto-Renews for 3 Years, Unless Earlier Terminated with Its Terms
THOMSON REUTERS  ·  09-09
Amylyx Pharmaceuticals - Bachem Manufacturing Agreement Has Initial 5 Year Term, Auto-Renews for 3 Years, Unless Earlier Terminated with Its Terms
Amylyx Pharmaceuticals - Enters Manufacturing Agreement with Bachem Americas on Sept 8, 2026 - SEC Filing
THOMSON REUTERS  ·  09-09
Amylyx Pharmaceuticals - Enters Manufacturing Agreement with Bachem Americas on Sept 8, 2026 - SEC Filing
Amylyx Signs Bachem Manufacturing Deal for Avexitide Supply Starting 2028
Reuters  ·  09-09
Amylyx Signs Bachem Manufacturing Deal for Avexitide Supply Starting 2028

Introduction

Company Name.
Amylyx Pharmaceuticals
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Issue price:
--